Section
Programs
4 pages in this section, most recently updated September 4, 2026. Each opens with a plain-English summary and cites its sources.
01 · Programs
FeaturedLillyDirect self-pay: Zepbound vials, KwikPen tiers and the 45-day refill rule
You'll get: LillyDirect is Lilly's own pharmacy. It sells Zepbound to cash payers for $299 to $449 a month depending on strength.
How Lilly's self-pay program works as of September 2026: the $299 to $449 Zepbound tiers, the prices outside the 45-day window, and what is included.
Updated September 4, 2026
02 · Programs
FeaturedNovoCare Pharmacy self-pay: Wegovy and Ozempic prices, the $199 introduction and the subscription
You'll get: NovoCare Pharmacy is Novo Nordisk's cash channel for Wegovy and Ozempic, with free delivery and no insurance needed.
How Novo Nordisk's self-pay channel works as of September 2026: $199 for two fills then $349, the pill prices, the prepaid subscription, and a real month.
Updated September 4, 202603 · Programs
FeaturedGLP-1 savings cards: floors, per-fill caps, annual caps and expiry dates
You'll get: A savings card is a manufacturer coupon that pays part of your copay after commercial insurance has paid its share.
Manufacturer savings-card terms for Zepbound, Mounjaro, Wegovy, Ozempic, Foundayo and Saxenda as of September 2026, with examples of when $25 holds.
Updated September 4, 202604 · Programs
TrumpRx and the November 2025 pricing agreement: what changed for GLP-1 prices
You'll get: In November 2025, Lilly and Novo Nordisk agreed with the US government to lower GLP-1 prices for Medicare, Medicaid and cash payers.
What the November 2025 agreements between the US government, Lilly and Novo Nordisk set for GLP-1 prices, and what TrumpRx.gov shows in September 2026.
Updated September 4, 2026